ROR1 expression correlated with poor clinical outcome in human ovarian cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ROR1 expression correlated with poor clinical outcome in human ovarian cancer
Authors
Keywords
-
Journal
Scientific Reports
Volume 4, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-07-24
DOI
10.1038/srep05811
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Use of Laser Microdissection in the Identification of Suitable Reference Genes for Normalization of Quantitative Real-Time PCR in Human FFPE Epithelial Ovarian Tissue Samples
- (2014) Jing Cai et al. PLoS One
- Timing and Pattern of Recurrence in Ovarian Cancer Patients with High Tumor Dissemination Treated with Primary Debulking Surgery Versus Neoadjuvant Chemotherapy
- (2013) M. Petrillo et al. ANNALS OF SURGICAL ONCOLOGY
- Selection and Characterization of Human Anti-MAGE-A1 scFv and Immunotoxin
- (2013) Hong Lin et al. Anti-Cancer Agents in Medicinal Chemistry
- Low expression of the X-linked ribosomal protein S4 in human serous epithelial ovarian cancer is associated with a poor prognosis
- (2013) Serges P Tsofack et al. BMC CANCER
- Targeting ROR1 Inhibits Epithelial-Mesenchymal Transition and Metastasis
- (2013) B. Cui et al. CANCER RESEARCH
- In vivodelivery of siRNA targeting vasohibin-2 decreases tumor angiogenesis and suppresses tumor growth in ovarian cancer
- (2013) Takahiro Koyanagi et al. CANCER SCIENCE
- Bevacizumab treatment and quality of life in advanced ovarian cancer
- (2013) Silvana Canevari et al. Future Oncology
- Interferon-gamma in ascites could be a predictive biomarker of outcome in ovarian carcinoma
- (2013) Yu-Li Chen et al. GYNECOLOGIC ONCOLOGY
- The Wnt/β-catenin pathway in ovarian cancer: A review
- (2013) Rebecca C. Arend et al. GYNECOLOGIC ONCOLOGY
- A novel human Fab antibody for Trop2 inhibits breast cancer growthin vitroandin vivo
- (2013) Hong Lin et al. INTERNATIONAL JOURNAL OF CANCER
- Is Routine Appendectomy at the Time of Primary Surgery for Mucinous Ovarian Neoplasms Beneficial?
- (2013) Tomer Feigenberg et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Basigin-2 is the predominant basigin isoform that promotes tumor cell migration and invasion and correlates with poor prognosis in epithelial ovarian cancer
- (2013) Shu-Hua Zhao et al. Journal of Translational Medicine
- Effect of leuprolide acetate on ovarian function after cyclophosphamide–doxorubicin-based chemotherapy in premenopausal patients with breast cancer: results from a phase II randomized trial
- (2013) Guiping Song et al. MEDICAL ONCOLOGY
- Biomarker Testing for Ovarian Cancer: Clinical Utility of Multiplex Assays
- (2013) Brian M. Nolen et al. Molecular Diagnosis & Therapy
- Inhibition of the Receptor Tyrosine Kinase ROR1 by Anti-ROR1 Monoclonal Antibodies and siRNA Induced Apoptosis of Melanoma Cells
- (2013) Mohammad Hojjat-Farsangi et al. PLoS One
- Increased expression of Trop2 correlates with poor survival in extranodal NK/T cell lymphoma, nasal type
- (2013) Renjie Chen et al. VIRCHOWS ARCHIV
- Generation and Characterization of a Novel Recombinant Antibody against LMP1-TES1 of Epstein-Barr Virus Isolated by Phage Display
- (2013) Dawei Zhang et al. Viruses-Basel
- The Onco-Embryonic Antigen ROR1 Is Expressed by a Variety of Human Cancers
- (2012) Suping Zhang et al. AMERICAN JOURNAL OF PATHOLOGY
- NKX2-1/TITF1/TTF-1-Induced ROR1 Is Required to Sustain EGFR Survival Signaling in Lung Adenocarcinoma
- (2012) Tomoya Yamaguchi et al. CANCER CELL
- Ovarian Cancer Risk Associated with Inherited Inflammation-Related Variants
- (2012) K. L. White et al. CANCER RESEARCH
- Orphan receptor tyrosine kinases ROR1 and ROR2 in hematological malignancies
- (2012) Amir Hossein Daneshmanesh et al. LEUKEMIA & LYMPHOMA
- ROR1 Is Expressed in Human Breast Cancer and Associated with Enhanced Tumor-Cell Growth
- (2012) Suping Zhang et al. PLoS One
- ROR1 and ROR2 in Human Malignancies: Potentials for Targeted Therapy
- (2012) Guilly Rebagay et al. Frontiers in Oncology
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Ror1 Is a Pseudokinase That Is Crucial for Met-Driven Tumorigenesis
- (2011) A. Gentile et al. CANCER RESEARCH
- ROR1 is expressed on hematogones (non-neoplastic human B-lymphocyte precursors) and a minority of precursor-B acute lymphoblastic leukemia
- (2011) H. Elizabeth Broome et al. LEUKEMIA RESEARCH
- A Human Fab-Based Immunoconjugate Specific for the LMP1 Extracellular Domain Inhibits Nasopharyngeal Carcinoma Growth In Vitro and In Vivo
- (2011) R. Chen et al. MOLECULAR CANCER THERAPEUTICS
- Silencing of ROR1 and FMOD with siRNA results in apoptosis of CLL cells
- (2010) Aniruddha Choudhury et al. BRITISH JOURNAL OF HAEMATOLOGY
- β-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis
- (2010) F. Klemm et al. CARCINOGENESIS
- Pharmacogenomics of Taxane/Platinum Therapy in Ovarian Cancer
- (2010) Sharon Marsh INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- WNT signaling in ovarian follicle biology and tumorigenesis
- (2009) Alexandre Boyer et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy
- (2008) Amir H. DaneshManesh et al. INTERNATIONAL JOURNAL OF CANCER
- Ror receptor tyrosine kinases: orphans no more
- (2008) Jennifer L. Green et al. TRENDS IN CELL BIOLOGY
- Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
- (2008) Martin Köbel et al. PLOS MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search